307 related articles for article (PubMed ID: 20952062)
21. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
[TBL] [Abstract][Full Text] [Related]
22. A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.
Impera L; Albano F; Lo Cunsolo C; Funes S; Iuzzolino P; Laveder F; Panagopoulos I; Rocchi M; Storlazzi CT
Oncogene; 2008 Oct; 27(47):6187-90. PubMed ID: 18622426
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic utility of t(14;18) in follicular lymphoma.
Deghiedy H; Fouda M; Shahin D; Shamaa S; El-Bedewy A; Abd El-Ghaffar H
Acta Haematol; 2007; 118(4):231-6. PubMed ID: 18075243
[TBL] [Abstract][Full Text] [Related]
24. Cryptic insertion of BCL2 gene into immunoglobulin heavy locus in follicular lymphoma with t(6;9)(p23;p13).
Yamamoto K; Okamura A; Inui Y; Yakushijin K; Murayama T; Matsuoka H; Minami H
Leuk Res; 2012 Sep; 36(9):e202-5. PubMed ID: 22658849
[No Abstract] [Full Text] [Related]
25. Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products.
Wickham CL; Harries LW; Sarsfield P; Joyner MV; Ellard S
Clin Lab Haematol; 2006 Aug; 28(4):248-53. PubMed ID: 16898964
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Herry A; Morel F; De Braekeleer M
Cytogenet Genome Res; 2007; 118(2-4):345-52. PubMed ID: 18000389
[TBL] [Abstract][Full Text] [Related]
27. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE
Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988
[TBL] [Abstract][Full Text] [Related]
28. Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas.
Streubel B; Scheucher B; Valencak J; Huber D; Petzelbauer P; Trautinger F; Weihsengruber F; Mannhalter C; Cerroni L; Chott A
Am J Surg Pathol; 2006 Apr; 30(4):529-36. PubMed ID: 16625101
[TBL] [Abstract][Full Text] [Related]
29. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
30. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
31. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
[TBL] [Abstract][Full Text] [Related]
32. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
[TBL] [Abstract][Full Text] [Related]
33. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
34. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
[TBL] [Abstract][Full Text] [Related]
35. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma.
Yin CC; Luthra R
Methods Mol Biol; 2013; 999():203-9. PubMed ID: 23666699
[TBL] [Abstract][Full Text] [Related]
36. BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma.
Goodlad JR; Batstone PJ; Hamilton DA; Kernohan NM; Levison DA; White JM
Histopathology; 2006 Sep; 49(3):229-41. PubMed ID: 16918969
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
38. Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor.
Zeng W; Meck J; Cheson BD; Ozdemirli M
J Cutan Pathol; 2011 Dec; 38(12):999-1003. PubMed ID: 21883369
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.
Chen W; Palanisamy N; Schmidt H; Teruya-Feldstein J; Jhanwar SC; Zelenetz AD; Houldsworth J; Chaganti RS
Oncogene; 2001 Nov; 20(52):7686-93. PubMed ID: 11753646
[TBL] [Abstract][Full Text] [Related]
40. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
